Présentation de l'entreprise
HealthEquity, Inc. operates as a provider of technology-enabled services platforms serving consumers and employers throughout the United States, primarily facilitating health savings accounts (HAS) and offering an investment platform alongside online-only automated investment advisory services delivered via Advisor, a web-based tool. The company functions within the Healthcare sector, specifically the Health Information Services industry, which implies a focus on leveraging digital infrastructure to manage financial assets linked to health expenses rather than delivering direct clinical care. With a market capitalization of 7.00B dollars and annual revenue of 1.31B dollars, the entity manages significant assets under management while supporting a workforce of 2814 employees. These valuation and revenue figures indicate that HealthEquity has established itself as a substantial entity within its niche, possessing a capitalization that suggests mature market presence and operational scale sufficient to support complex financial technology operations.
Santé financière
The company reported trailing twelve-month revenue of 1.31B dollars and net income of 215.20M dollars, with an EBITDA figure of 482.14M dollars, revealing a cost structure where operational expenses consume a significant portion of gross revenue before reaching the bottom line. The gap between the 1.31B dollar revenue and the 215.20M dollar net income highlights the substantial fixed costs associated with maintaining the technology platforms and advisory services necessary to serve the consumer and employer base. Free cash flow stands at 338.05M dollars, indicating robust financial flexibility that allows the company to service its obligations, invest in technological upgrades, or potentially acquire complementary businesses without immediate reliance on external financing. Gross margin is reported at 69.5%, operating margin at 21.6%, and profit margin at 16.4%, demonstrating that while the company retains nearly 70% of sales as gross profit, operational efficiencies result in roughly one-fifth of revenue remaining after overhead, and final profitability settles at approximately 16.4% of sales. Total cash holdings of 318.93M dollars are significantly lower than total debt of 1.00B dollars, resulting in a debt-to-equity ratio of 47.53, which characterizes the balance sheet as leveraged rather than conservative, necessitating careful monitoring of interest rate fluctuations. The current ratio of 3.27 suggests strong short-term liquidity, as current assets are more than three times current liabilities, providing a substantial buffer against immediate payment obligations. Return on equity is 10.2% and return on assets is 6.0%, metrics that reveal management is generating double-digit returns on shareholder equity while maintaining moderate asset efficiency relative to the total asset base.
Évaluation de la valorisation
The trailing twelve-month P/E ratio is 33.31 while the forward P/E is 15.34, implying that the market expects a significant acceleration in earnings growth over the coming year, as the forward multiple is less than half the trailing multiple. The price-to-book ratio stands at 3.31, indicating that the market values the company at more than three times its book value, reflecting a premium assigned to its intangible assets, technology platforms, and recurring revenue streams. Price-to-sales is 5.33 and EV/EBITDA is 15.78, suggesting that investors are willing to pay a high multiple relative to sales given the high growth expectations, while the EV/EBITDA multiple of 15.78 points to a valuation that is elevated compared to traditional utility or low-growth sectors but may be justified by the high forward growth rate. The 52-week high is 116.65 and the 52-week low is 72.76, establishing a trading range of approximately 43.89 dollars; without the specific current share price in the provided facts, the relative position to this range cannot be calculated, but the spread between the high and low demonstrates considerable intrayear volatility. The beta is 0.26, indicating that the stock's price volatility is substantially lower than the broader market, suggesting that price movements are less sensitive to general market swings and more driven by company-specific factors.
Growth & Income
Revenue growth year over year is 7.3% and earnings growth year over year is 92.4%, demonstrating that earnings are growing at a rate vastly faster than revenue, which implies potential leverage effects from fixed cost structures or one-time gains impacting the bottom line more aggressively than top-line sales expansion. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that all net income of 215.20M dollars is reinvested into the business to fund growth initiatives, technology development, or debt reduction rather than being distributed to shareholders. The combination of 92.4% earnings growth and a 7.3% revenue expansion profile creates a high-growth income trajectory typical of companies in the expansion phase of their lifecycle, relying on retained earnings to fuel future performance. The overall growth and income profile is characterized by aggressive earnings expansion supported by a reinvestment strategy, with no reliance on dividend income for investors.